Therapeutic time window from diagnosis to treatment for elderly AML patients

Matteo Molica, Hematologist Medical Director at UOC Hematology Oncohaematology Department at the Apulian Ciaccio Hospital, shared on LinkedIn:

““Is there a better therapeutic time window from diagnosis to treatment for elderly acute myeloid leukemia (AML) patients receiving hypomethylating agents?”

New paper on acute myeloid leukemia. Thanks to all colleagues.”